Lung Cancer Study Group
N E W S - A R C H I V E
The 10th GECP Congress, which opens the Portuguese Lung Cancer Congress, will take place on the 20th, 21st and 22nd of October, in Troia, in an entirely face-to-face format. In this event, under the theme “Lugar ao Novo”, “we will…
“Don’t gamble with your life” is the alert from the Lung Cancer Study Group (GECP) on the occasion of the International Gamer Day, celebrated annually on August 29, with the aim of putting the topic of lung cancer on the…
Men Made Cancer: “Lung cancer is the biggest killer, but its main risk factors are modifiable” “Men Made Cancer” is the motto of the new campaign by the Lung Cancer Study Group (GECP) for World Lung Cancer Day, which is…
The drug Tecentriq (atezolizumab) obtained authorization from the National Authority for Medicines and Health Products (Infarmed) to be used in hospitals in new indications for the treatment of lung cancer. According to the grant recently published on the Infarmed website,…
Dr. Fernanda EstevinhoOncologist at Hospital Pedro Hispano – ULS MatosinhosSelected Article: “Effectiveness of PD-(L)1 inhibitors alone or in combination with platinum doublet chemotherapy in first-line (1L) non-squamous non-small-cell lung cancer (Nsq-NSCLC) with PD-L1-high expression using real-world data” O artigo selecionado…
To celebrate this anniversary, we recall the GECP’s journey through the most used digital communication networks around the world.After our debut on Facebook and Instagram in May 2020, we created an institutional page on LinkedIn last year.At a time when…
Lung cancer is more than smoking” is the motto of the GECP campaign to mark the World No Tobacco Day, which is celebrated annually on the 31st of May.Today we focus on demystifying the stigma associated with lung cancer, warning…
GECP has just launched another digital initiative that aims to promote regular scientific updating and the sharing of ideas among peers. It is entitled “Selected Article” and gives voice to the members of the Scientific Committee of the GECP, inviting…
As part of the webinar “Lung Cancer: together for a more promising future”, a group of representatives from the Portuguese Pneumology Society (Prof. Dr. António Morais), from the Lung Cancer Study Group (Dr. Teresa Almodovar), from the Portuguese League Against…
On May 18, to mark the European Oncology Nursing Day, the Lung Cancer Study Group (GECP) and the Portuguese Oncology Nursing Association (AEOP) launched a tribute campaign to all oncologist nurses. To celebrate this date, we invited three nurses to…
The Hotel Vila Galé, in Coimbra, will host a meeting organized jointly by the Lung Cancer Study Group (GECP) and the Respiratory Diseases Study Group (GRESP) of the Portuguese Association of General and Family Medicine (APMGF), with support of the…
After the recent opening of two Early Access Programs (PAP) to tepotinib and amivantamab (see news here!) for the treatment of two subtypes of lung cancer, INFARMED granted the request for a PAP to nivolumab in combination with ipilimumab for…
